user

Heart Matters

Copyright 2026 ReachMD. All rights reserved.
    1
    Average play count
    185
    Played
    0
    Subscribers
    Understanding the Mechanisms Behind Resistant Hypertension
    Host: Steve Jackson, PharmD Guest: Jan Basile, MD Guest: Michael J. Bloch, MD, FAHA, FASH, FNLA When blood pressure remains uncontrolled despite treatment, adding more medication...
    • 1
    • 2 months ago
    12:45
    Quality of Life Conversations in ATTR-CM Care
    Guest: Kevin S. Shah, MD Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience significant quality of life challenges that extend beyond cardiac symptoms, includi...
    • 1
    • 3 months ago
    02:45
    Hypertension Across Diverse Populations: Practical Strategies for Equitable Care
    Host: Alexandria May, PharmD, BCPS Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA Hypertension is a key modifiable cardiovascular risk factor, but its prevalence, pro...
    • 1
    • 3 months ago
    12:15
    Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
    Guest: Joban Vaishnav, MD For patients newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), it's essential to set realistic expectations and prioritize whole-pers...
    • 1
    • 4 months ago
    02:30
    Counseling Patients on Disease Progression in ATTR-CM
    Guest: Joban Vaishnav, MD When transthyretin amyloid cardiomyopathy (ATTR-CM) progresses, an individualized and empathetic approach to patient conversations is key. Hear from Dr. Job...
    • 1
    • 4 months ago
    02:45
    AI-Driven Advances in ATTR-CM Care
    Guest: Frederick Ruberg, MD Artificial intelligence has rapidly advanced disease recognition in transthyretin amyloid cardiomyopathy (ATTR-CM), and its role in guiding treatment selectio...
    • 1
    • 5 months ago
    03:15
    Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
    Guest: Kevin Alexander In the past decade, significant strides have been made in diagnosing and treating patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Increased disease a...
    • 1
    • 7 months ago
    04:45
    Treating ATTR-CM Early: A Shift From Reactive to Strategic Care
    Guest: Quan Bui, MD Quality of life in transthyretin cardiac amyloidosis (ATTR-CM) varies widely by disease stage, but early detection and treatment can make a profound differenc...
    • 1
    • 7 months ago
    02:45
    Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
    Host: Laurence S. Sperling, MD, FACC, FAHA, FACP, MASPC Guest: Eugenia Gianos, MD Cholesterol management is evolving, but new data presented at the 2025 American Heart Association (A...
    • 1
    • 8 months ago
    17:30
    Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
    Guest: Susan Davis Emerging research is challenging long-held assumptions about the roles of estrogen and testosterone in women’s health—particularly in the context of aging and cardiome...
    • 1
    • 9 months ago
    04:45
    Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
    A recent study explored the emerging role of KCNQ5 potassium channels in vascular smooth muscle regulation and their potential as therapeutic targets to promote vasodilation and manage blood...
    • 1
    • 9 months ago
    04:45
    Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
    Guest: Jun-ichi Abe, MD, PhD Cancer therapies can trigger both acute and chronic vascular effects, from treatment-induced hypertension to long-term atherosclerotic changes. Learn more as...
    • 1
    • 9 months ago
    03:15
    Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
    Understanding how lipids and lipoproteins are formed, metabolized, and cleared is essential for accurate lipid interpretation and cardiovascular risk assessment. Hear from Dr. Robert Eckel a...
    • 1
    • 10 months ago
    05:00
    Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
    Sex-based differences in lipid metabolism can have critical impacts on cardiovascular risk assessment and treatment. Hear from Dr. Connie Newman as she explains why understanding lipid metab...
    • 1
    • 10 months ago
    03:45
    Gender Bias and Heart Health: Improving Cardiovascular Care for Women
    Cardiovascular disease is the leading cause of mortality in women, yet it is often underrecognized due to gender bias in healthcare. Hear from Dr. Connie Newman as she explores the impact of...
    • 1
    • 10 months ago
    03:15
    Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
    Effective lipid management depends on identifying how specific dietary factors drive LDL cholesterol and triglyceride elevations. Dr. Robert Eckel shares evidence-based strategies for tailor...
    • 1
    • 11 months ago
    04:45
    Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
    Statin intolerance, though uncommon, presents a challenge for patients who experience persistent side effects despite adjustments in dosing or switching statins. Dr. Matthew Sorrentino revie...
    • 1
    • 11 months ago
    04:45
    Improving Lipid Management Through Equity-Focused Clinical Strategies
    Despite advances in lipid-lowering therapies, disparities in hyperlipidemia diagnosis and treatment persist. Dr. Keith Ferdinand examines how social drivers of health impact access, adherenc...
    • 1
    • 11 months ago
    04:30
    Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care
    Effective management of hyperlipidemia requires tailoring treatment to a patient’s cardiovascular risk profile. Lifestyle modification remains the cornerstone of care, while high-risk patien...
    • 1
    • 11 months ago
    03:45
    How Artificial Sweeteners Could Be Linked to Heart Disease
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Wilson Tang, MD Many different artificial sweeteners are being consumed by patients; however, this discussion will focus ...
    • 1
    • 2 years ago
    14:30
    Active Aging: Preventing Heart Failure in Older Women with Exercise
    Host: Javed Butler, MD Guest: Michael J. LaMonte, PhD, MPH The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise ...
    • 1
    • 2 years ago
    12:30
    Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
    Host: Javed Butler, MD Guest: Jeffrey Wilson, MD There’s a decent amount of evidence showing allergic immune responses could have connections with heart disease. But with the knowled...
    • 1
    • 2 years ago
    12:00
    AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
    Host: Javed Butler, MD Guest: Chiadi Ndumele, M.D., Ph.D., M.H.S. For the first time, the American Heart Association (AHA) has identified cardiovascular-kidney-metabolic (CKM) syndro...
    • 1
    • 2 years ago
    13:00
    Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Dave L. Dixon, PharmD, FACC,  FCCP, FNLA, BCPS, BCACP, CDE, CLS What would the cost-effectiveness look like if the uptake...
    • 1
    • 2 years ago
    12:00
    Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Javed Butler, MD There’s no approved therapies specifically targeting obesity and HFpEF, but based on the STEP-HFpEF stud...
    • 1
    • 2 years ago
    12:00
    A Discussion on Statins to Lower CVD Risk for HIV Patients
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Steve Grinspoon, MD The risk of cardiovascular disease is twice as great among patients living with HIV, and this could p...
    • 1
    • 3 years ago
    12:00
    A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA The National Lipid Association (NLA) recently published updated recommendatio...
    • 1
    • 3 years ago
    11:30
    Identifying Cardiovascular Risk Factors for HIV Patients
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Steve Grinspoon, MD Many studies over the last few years have shown that the risks of cardiovascular disease have increas...
    • 1
    • 3 years ago
    13:30
    Exploring Emerging Non-Statin LDL Lowering Therapies
    Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Maya S. Safarova, MD, PhD, FNLA Learn which patients with low-density lipoprotein (LDL) would benefit from this group of medication. ...
    • 1
    • 3 years ago
    13:00
    Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Alan S. Brown, MD, FACC, FAHA, FNLA Both clinical trials for lowering Lp(a) had patients with established atherosclerotic...
    • 1
    • 3 years ago
    10:00
    Stanford Surgeons Perform First Beating-Heart Procedure
    Host: Javed Butler, MD Guest: John W. MacArthur With many barriers standing in the way of people in the United States who need a heart transplant, fewer than 10 percent of patients a...
    • 1
    • 3 years ago
    12:00
    Treating Tricuspid Valve Regurgitation With Novel Replacement Device
    Host: Javed Butler, MD Guest: Pedro A Villablanca Spinetto, MD A complex condition known as tricuspid valve regurgitation may cause concern for patients as it typically doesn’t show ...
    • 1
    • 3 years ago
    11:00
    Exploring the Use of AI to Detect HFpEF
    Guest: Patricia A. Pellikka, M.D. Artificial intelligence (AI) has several applications in cardiology, such as echocardiography. Can machine learning and AI algorithms in echocardiology ...
    • 1
    • 3 years ago
    03:30
    Updates from ACC 2023: Examining Transcatheter Repair Study Data
    Guest: Paul Sorajja, MD TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improv...
    • 1
    • 3 years ago
    03:00
    Cardio-Oncology: Key Clinical Data from ACC.23
    Guest: Ana Barac, MD, PhD The American College of Cardiology's 72nd Scientific Session & Expo featured the latest advancements in all fields of cardiovascular medicine, including car...
    • 1
    • 3 years ago
    03:30
    The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
    Host: Javed Butler, MD Guest: Ana Barac, MD, PhD Cardio-oncology is a novel field in cardiovascular medicine that has rapidly grown over the past few years. What kind of role does mu...
    • 1
    • 3 years ago
    07:30
    The STELLAR Trial: Key Data on Sotatercept for PAH
    Host: Marius M. Hoeper, MD A recent study explored the safety and efficacy of sotatercept on top of background pulmonary arterial hypertension (PAH) therapy. To learn more about this cli...
    • 1
    • 3 years ago
    03:00
    A Look at Lipoprotein(a): Key Screening & Treatment Strategies
    According to the CDC, patients with familial hypercholesterolemia or patients who show signs of coronary heart disease are at an increased chance of having heart attack, stroke, and aortic s...
    • 1
    • 3 years ago
    12:00
    Anticipated Updates on Statin Intolerance at ACC 2023
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiolo...
    • 1
    • 3 years ago
    05:00
    The Role of Implementation Science in Familial Hypercholesterolemia
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Laney K. Jones, PharmD, MPH Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coron...
    • 1
    • 3 years ago
    08:00
    Updated Guidelines for Youth With Dyslipidemia
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Lauren Williams, MCN,RD,LD Kids with dyslipidemia don’t have much different nutritional needs than other young kids their...
    • 1
    • 3 years ago
    10:30
    A Look into the Effectiveness of Dietary Supplements
    Host: Matthew Sorrentino, MD Guest: Luke Laffin, MD Six commonly used supplements thought to improve patients’ cholesterol may be doing more harm than good. So what do we need to kno...
    • 1
    • 3 years ago
    10:30
    Uncovering the Results of the DELIVER Trial
    Host: Javed Butler, MD Guest: Scott Solomon, MD Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER trial) is a study designed to assess the ef...
    • 1
    • 3 years ago
    11:30
    Exploring Novel Tools for PAH: Measuring Severity With a New Blood Test
    Host: Matthew Sorrentino, MD Guest: Michael A. Solomon, MD, MBA Guest: Sean Agbor-Enoh, MD, PhD Pulmonary arterial hypertension (PAH) is a rare, and even fatal, condition that ca...
    • 1
    • 3 years ago
    14:00
    Investigating the Link Between PCOS & CV Risk Factors During Delivery
    Host: Hector O. Chapa, MD, FACOG Guest: Erin Michos Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous r...
    • 1
    • 4 years ago
    10:00
    When Climate & Cardiology Overlap: How Climate Change Can Impact Heart Health
    Host: Javed Butler, MD Guest: Sameed Khatana, MD, MPH As global temperatures continue to rise, experts are calling attention to the devastating effects this can have on human health....
    • 1
    • 4 years ago
    12:30
    The miniPUMP: A New Way to Get a Close-Up View of the Heart
    Host: Javed Butler, MD Guest: Alice White, PhD Guest: Christopher Chen, MD, PhD There is currently no safe way to get a close-up view of the human heart, which is exactly why a t...
    • 1
    • 4 years ago
    10:30
    Improving Adherence Among HF Patients: A Look at the PROMPT-HF Trial
    Host: Javed Butler, MD Guest: Tariq Ahmad, MD, MPH The Pragmatic Trial of Messaging to Providers About Treatment in Heart Failure (PROMPT-HF) was designed to test the hypothesis that...
    • 1
    • 4 years ago
    10:00
    What the SODIUM-HF Trial Means for Heart Failure Patients
    Host: Javed Butler, MD Guest: Justin Ezekowitz, MD, MBBCh, MSc The Study of Dietary Intervention under 100 millimole in Heart Failure (SODIUM-HF) trial was designed to assess the eff...
    • 1
    • 4 years ago
    13:00
    Breaking Down the Criteria for Iron Deficiency in Heart Failure
    Host: Javed Butler, MD Guest: John Cleland Guest: Fraser Graham, MD Iron deficiency is one of the most frequent comorbidities in patients with heart failure and is estimated to p...
    • 1
    • 4 years ago
    10:00
    English